Conference Call Participants
Paul Matteis – Stifel Nicolaus Canada Inc., Research Division
Presentation
Paul Matteis
Stifel Nicolaus Canada Inc., Research Division
Great. Thanks, everybody, for continuing on here. It’s my pleasure to be moderating a chat with Ryan Watts, Founder and CEO of Denali. I’m sure most folks know the story decently well. But maybe, Ryan, you can just give us a couple of minutes to sort of set the stage on 2026 is a big year for Denali with Hunter and the pipeline, and then we’ll do Q&A. So thanks again.
Ryan Watts
Co-Founder, President, CEO & Director
Sounds great, Paul. Great to be here again. I was trying to count how many CNS days this is for me, but probably…
Paul Matteis
Stifel Nicolaus Canada Inc., Research Division
6 or 7. Do you know the first one was not on video. Well, no, I’ve done 7. The first one for you was probably 6 years ago, audio-only 5 days into COVID.
Ryan Watts
Co-Founder, President, CEO & Director
Yes. I remember that.
Paul Matteis
Stifel Nicolaus Canada Inc., Research Division
Crazy. So thank you. Appreciate it.
Ryan Watts
Co-Founder, President, CEO & Director
It’s good to be back. And I think that might have even been a panel, if I recall, back…
Paul Matteis
Stifel Nicolaus Canada Inc., Research Division
Yes, that was interesting. We can talk about that another time. That was interesting.
Ryan Watts
Co-Founder, President, CEO & Director
I mean, 2026 is set up to be a very important year for Denali. I mean, obviously, we’re at the very final stages of our first approval for tividenofusp alfa in Hunter syndrome. I think not